Lotte 3rd Generation Shin Yuyeol Acquires Additional 4,000 Shares of Lotte Holdings Korea

Approximately 1 Billion KRW... "To Enhance Corporate Value and Promote Responsible Management"

Shin Yoo-yeol, Executive Director of Future Growth at Lotte Holdings (Senior Executive Vice President), has purchased an additional 4,000 shares of Lotte Holdings stock. Shin is the eldest son of Shin Dong-bin, Chairman of Lotte.

According to the Financial Supervisory Service's electronic disclosure system (DART) on the 5th, Shin purchased 4,255 shares of Lotte Holdings stock on the 3rd. The acquisition price per share was 24,454 KRW, with a total purchase cost of approximately 100 million KRW.

As a result, Shin's holdings of Lotte Holdings stock increased to 11,796 shares, accounting for 0.01% of the total issued shares of Lotte Holdings. Previously, Shin had also purchased 7,541 shares of Lotte Holdings stock in June.

Regarding this, a Lotte official explained, "(Shin) purchased the shares to enhance corporate value and demonstrate responsible management."

Shin was promoted from Managing Director to Executive Director at the end of last year. This came one year after his promotion to Managing Director of the Basic Materials Division at Lotte Chemical at the end of 2022. He concurrently holds the positions of Executive Director of Future Growth at Lotte Holdings and Head of Global Strategy at Lotte Biologics. In February, he was appointed as an inside director of Lotte Biologics, becoming the first registered executive officer among Korean Lotte Group affiliates. In June, he was also appointed as an inside director of Lotte Holdings, the holding company of Lotte in Japan.

In the business community, this is interpreted as the formal commencement of Shin's succession process for management rights. Inside directors participate in the board of directors, which decides on important company matters. By serving as an inside director in both Korea (Lotte Biologics) and Japan (Lotte Holdings), Shin will actively engage in group management.

Meanwhile, after appointing Shin as an inside director, Lotte Holdings also established a corporate venture capital (CVC) for the bio-pharmaceutical business. Lotte Holdings plans to promote businesses that can create new added value by linking Japan and Korea.